How much is the cervical cancer vaccine for a 30-year-old?

It is generally recommended that women aged 30 years old receive the nine-valent cervical cancer vaccine.

The nine-valent cervical cancer vaccine is suitable for women aged 16-45. It can prevent cervical cancer and precancerous lesions caused by HPV types 16, 18, 31, 33, 45, 52, and 58, and also covers genital warts caused by types 6 and 11. This vaccine requires 3 doses within 6 months, and the common vaccination schedule is one dose each at 0, 2, and 6 months. There is no need for HPV testing before vaccination, but people infected with certain types of HPV can still benefit from protection against other types. After vaccination, minor reactions such as pain, redness, swelling or low-grade fever at the injection site may occur, which usually resolve spontaneously in 2-3 days. It should be noted that the vaccine cannot replace routine cervical cancer screening, and regular TCT and HPV combined testing is still required after vaccination.

It is recommended to choose a regular medical institution for vaccination and observe for 30 minutes after vaccination. Avoid vaccination if you have fever, are pregnant, or are allergic to vaccine components. It is necessary to maintain a regular schedule and a balanced diet to maintain immunity. Reducing the number of sexual partners and insisting on using condoms can reduce the risk of HPV infection. Even if a 30-year-old woman is past the optimal vaccination age, vaccination can still significantly reduce the probability of cervical cancer.